4D Molecular Therapeutics Inc (FDMT): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 28,091 US Dollar | 9 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 55.244.211 | 23,93 | 10,77 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name 4D Molecular Therapeutics Inc
Mitarbeiter 196
Handelsplatz NASDAQ
Ticker Symbol FDMT
IPO Datum 2020-12-11
Adresse 5858 Horton Street, EmeryVille, CA, United States, 94608
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. John F. Milligan Ph.D. | Executive Chairman |
| 2 | Dr. David H. Kirn M.D. | Co-Founder, President, CEO & Director |
| 3 | Mr. Kristian Humer M.B.A. | CFO and Principal Financial & Accounting Officer |
| 4 | Dr. Fariborz Kamal Ph.D. | Chief Technical Advisor |
| 5 | Ms. Theresa Janke | Co-Founder & Chief of Staff |
| 6 | Julian Pei | Head of Investor Relations & Corporate Finance |
| 7 | Dr. Katy Barglow Ph.D. | Chief Technical Officer |
| 8 | Dr. Scott P. Bizily J.D., Ph.D. | Chief Legal Officer & Corporate Secretary |
| 9 | Dr. An Song Ph.D. | Chief Translational Medicine Advisor |
| 10 | Dr. Noriyuki Kasahara M.D., Ph.D. | Chief Scientific Advisor |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | ArrowMark Colorado Holdings, LLC (ArrowMark Partners) | 0,37% | 2,62 Mio. USD |